Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Xenon Pharmaceuticals - 5 Year Stock Price History | XENE

Historical daily share price chart and data for Xenon Pharmaceuticals since 2014 adjusted for splits. The latest closing stock price for Xenon Pharmaceuticals as of August 21, 2019 is 9.00.
  • The all-time high Xenon Pharmaceuticals stock price is 23.00, which is 155.6% above the current share price.
  • The Xenon Pharmaceuticals 52-week high stock price is 14.90, which is 65.6% above the current share price.
  • The Xenon Pharmaceuticals 52-week low stock price is 5.61, which is 37.7% below the current share price.
  • The average Xenon Pharmaceuticals stock price for the last 52 weeks is 9.52.
  
Xenon Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 9.1605 6.6800 10.7500 6.3900 9.0000 42.63%
2018 7.6217 2.8750 14.9000 2.7000 6.3100 123.36%
2017 4.3814 7.8500 9.8500 2.2000 2.8250 -63.31%
2016 7.4501 7.9600 8.5500 5.8800 7.7000 -4.23%
2015 12.6255 18.7000 23.0000 7.6900 8.0400 -59.29%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.229B $0.000B
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.538B 14.07
Gilead Sciences (GILD) United States $81.192B 9.97
Celgene (CELG) United States $67.486B 10.44
Vertex Pharmaceuticals (VRTX) United States $48.089B 51.97
Biogen (BIIB) United States $43.478B 7.72
Illumina (ILMN) United States $42.432B 49.85
CSL (CSLLY) Australia $35.201B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.771B 14.87
Alexion Pharmaceuticals (ALXN) United States $25.266B 13.32
Incyte (INCY) United States $18.177B 53.49
Exact Sciences (EXAS) United States $15.300B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.892B 0.00
Seattle Genetics (SGEN) United States $12.839B 0.00
Genmab (GNMSF) Denmark $12.462B 63.35
Bio-Rad Laboratories (BIO.B) United States $9.886B 52.99
Guardant Health (GH) United States $9.236B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.141B 0.00
Sarepta Therapeutics (SRPT) United States $8.944B 0.00
Galapagos (GLPG) Belgium $8.582B 0.00
QIAGEN (QGEN) Netherlands $7.850B 25.78
Bio-Techne Corp (TECH) United States $7.344B 50.76
BeiGene (BGNE) Cayman Islands $7.041B 0.00
Exelixis (EXEL) United States $6.861B 17.83
Bluebird Bio (BLUE) United States $6.746B 0.00
Amarin (AMRN) Ireland $5.594B 0.00
Horizon Pharma Public (HZNP) Ireland $5.127B 13.03
Ascendis Pharma (ASND) Denmark $4.875B 0.00
Repligen (RGEN) United States $4.823B 93.60
Moderna (MRNA) United States $4.424B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.419B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.225B 0.00
Blueprint Medicines (BPMC) United States $3.992B 0.00
China Biologic Products (CBPO) China $3.912B 24.42
Spark Therapeutics (ONCE) United States $3.888B 0.00
MorphoSys AG (MOR) Germany $3.874B 0.00
Mirati Therapeutics (MRTX) United States $3.624B 0.00
Alkermes (ALKS) Ireland $3.469B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.426B 0.00
Immunomedics (IMMU) United States $2.849B 0.00
Arena Pharmaceuticals (ARNA) United States $2.822B 6.06
Genomic Health (GHDX) United States $2.768B 51.90
Amicus Therapeutics (FOLD) United States $2.676B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.656B 0.00
NeoGenomics (NEO) United States $2.649B 141.72
Medicines (MDCO) United States $2.633B 0.00
MyoKardia (MYOK) United States $2.536B 0.00
Acceleron Pharma (XLRN) United States $2.450B 0.00
Halozyme Therapeutics (HALO) United States $2.440B 0.00
Reata Pharmaceuticals (RETA) United States $2.358B 0.00
Emergent Biosolutions (EBS) United States $2.279B 34.23
Intercept Pharmaceuticals (ICPT) United States $2.165B 0.00
UniQure (QURE) Netherlands $2.152B 0.00
Akcea Therapeutics (AKCA) United States $2.042B 0.00
Cambrex (CBM) United States $1.993B 25.20
Zai Lab (ZLAB) China $1.976B 0.00
Myriad Genetics (MYGN) United States $1.853B 19.44
Ligand Pharmaceuticals (LGND) United States $1.846B 23.34
Denali Therapeutics (DNLI) United States $1.803B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.621B 0.00
Insmed (INSM) United States $1.506B 0.00
REGENXBIO (RGNX) United States $1.382B 0.00
Coherus BioSciences (CHRS) United States $1.375B 0.00
RA PHARMCTL INC (RARX) United States $1.362B 0.00
Sangamo Therapeutics (SGMO) United States $1.342B 0.00
AnaptysBio (ANAB) United States $1.321B 0.00
Editas Medicine (EDIT) United States $1.277B 0.00
Epizyme (EPZM) United States $1.262B 0.00
Fate Therapeutics (FATE) United States $1.242B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.227B 0.00
Athenex (ATNX) United States $1.214B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.204B 0.00
Innoviva (INVA) United States $1.173B 3.39
Alector (ALEC) United States $1.083B 0.00
Zymeworks (ZYME) Canada $0.989B 0.00
Twist Bioscience (TWST) United States $0.988B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.980B 0.00
Cara Therapeutics (CARA) United States $0.945B 0.00
Principia Biopharma (PRNB) United States $0.941B 490.63
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
Intellia Therapeutics (NTLA) United States $0.847B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.842B 0.00
Adverum Biotechnologies (ADVM) United States $0.833B 0.00
Cytokineticsorporated (CYTK) United States $0.821B 0.00
ANI Pharmaceuticals (ANIP) United States $0.817B 13.64
Vanda Pharmaceuticals (VNDA) United States $0.817B 29.48
Alder BioPharmaceuticals (ALDR) United States $0.813B 0.00
Arvinas (ARVN) United States $0.807B 0.00
Anika Therapeutics (ANIK) United States $0.792B 28.03
Codexis (CDXS) United States $0.769B 0.00
Retrophin (RTRX) United States $0.762B 0.00
Pharming Group (PHGUF) Netherlands $0.759B 0.00
Vericel (VCEL) United States $0.757B 0.00
WAVE Life Sciences (WVE) Singapore $0.745B 0.00
Zealand Pharma (ZLDPF) Denmark $0.664B 0.00
Stemline Therapeutics (STML) United States $0.663B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.650B 0.00
Zealand Pharma (ZEAL) Denmark $0.640B 7.42
MiMedx (MDXG) United States $0.611B 0.00
Heska (HSKA) United States $0.576B 74.64
DBV Technologies S.A (DBVT) France $0.552B 0.00
Cellectis S.A (CLLS) France $0.537B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.516B 0.00
Revance Therapeutics (RVNC) United States $0.503B 0.00
Intra-Cellular Therapies (ITCI) United States $0.501B 0.00
PHARMA MAR SA (PHMMF) Spain $0.501B 0.00
Precision BioSciences (DTIL) United States $0.494B 0.00
Syros Pharmaceuticals (SYRS) United States $0.474B 0.00
Mesoblast (MESO) Australia $0.470B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.459B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.436B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.434B 0.00
CytomX Therapeutics (CTMX) United States $0.434B 0.00
Merus (MRUS) Netherlands $0.422B 0.00
BioDelivery Sciences (BDSI) United States $0.398B 0.00
Puma Biotechnology (PBYI) United States $0.397B 0.00
Agenus (AGEN) United States $0.390B 0.00
AC Immune SA (ACIU) Switzerland $0.387B 28.65
AMAG Pharmaceuticals (AMAG) United States $0.379B 0.00
Avid Bioservices (CDMO) United States $0.374B 0.00
Gritstone Oncology (GRTS) United States $0.352B 0.00
Scholar Rock Holding (SRRK) United States $0.343B 0.00
Kadmon Holdings (KDMN) United States $0.333B 0.00
Arcus Biosciences (RCUS) United States $0.331B 0.00
Clovis Oncology (CLVS) United States $0.325B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Albireo Pharma (ALBO) United States $0.318B 0.00
Theratechnologies (THERF) Canada $0.316B 0.00
Prothena (PRTA) Ireland $0.315B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
Cel-Sci (CVM) United States $0.302B 0.00
Sorrento Therapeutics (SRNE) United States $0.301B 0.00
Protagonist Therapeutics (PTGX) United States $0.290B 0.00
Kindred Biosciences (KIN) United States $0.289B 0.00
PDL BioPharma (PDLI) United States $0.286B 7.35
Dynavax Technologies (DVAX) United States $0.282B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.274B 0.00
Geron (GERN) United States $0.266B 0.00
Senesco Technologies (ELOX) United States $0.250B 0.00
ADMA Biologics Inc (ADMA) United States $0.243B 0.00
Cellular Biomedicine (CBMG) United States $0.241B 0.00
Inovio Pharmaceuticals (INO) United States $0.241B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.237B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.234B 0.00
Seres Therapeutics (MCRB) United States $0.231B 0.00
Prometic Life Sciences (PFSCF) Canada $0.230B 0.00
ChromaDex (CDXC) United States $0.223B 0.00
MannKind (MNKD) United States $0.222B 0.00
Pfenex (PFNX) United States $0.222B 0.00
Five Prime Therapeutics (FPRX) United States $0.216B 0.00
Kamada (KMDA) Israel $0.216B 8.26
PHASEBIO PHARMA (PHAS) United States $0.215B 0.00
Athersys (ATHX) United States $0.205B 0.00
Sutro Biopharma (STRO) United States $0.203B 0.00
Compugen (CGEN) Israel $0.200B 0.00
CorMedix Inc (CRMD) United States $0.199B 0.00
Palatin Technologies (PTN) United States $0.195B 0.00
Cue Biopharma (CUE) United States $0.187B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.183B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
Dyadic (DYAI) United States $0.179B 0.00
Affimed (AFMD) Germany $0.177B 0.00
Novavax (NVAX) United States $0.174B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
POXEL SA FRANCE (PXXLF) $0.163B 0.00
Arsanis (XFOR) United States $0.161B 0.00
Emmaus Life Sciences (EMMA) United States $0.161B 0.00
Cerecor (CERC) United States $0.160B 0.00
OSMOTICA PHARM (OSMT) United States $0.159B 0.00
Alcobra (ARCT) United States $0.158B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.156B 0.00
XOMA (XOMA) United States $0.155B 0.00
Synlogic (SYBX) United States $0.153B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.150B 0.00
BioTime (LCTX) United States $0.150B 9.99
Strongbridge Biopharma (SBBP) United States $0.149B 6.11
Enzo Biochem (ENZ) United States $0.148B 0.00
Nicox SA (NICXF) France $0.147B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.144B 0.00
Acorda Therapeutics (ACOR) United States $0.141B 0.00
Adocia (ADOCY) France $0.140B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.125B 0.00
NantKwest (NK) United States $0.124B 0.00
Celyad SA (CYAD) Belgium $0.123B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.118B 0.00
Fortress Biotech (FBIO) United States $0.116B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Northwest Biotherapeutics (NWBO) United States $0.115B 0.00
TOCAGEN INC (TOCA) United States $0.113B 0.00
Abeona Therapeutics (ABEO) United States $0.110B 0.00
Aduro Biotech (ADRO) United States $0.110B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.109B 0.00
Checkpoint Therapeutics (CKPT) United States $0.107B 0.00
Liquidia Technologies (LQDA) United States $0.105B 0.00
Aptinyx (APTX) United States $0.104B 0.00
OvaScience (MLND) United States $0.098B 0.00
Verastem (VSTM) United States $0.096B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Menlo Therapeutics (MNLO) United States $0.091B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.087B 0.00
Trevena (TRVN) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.074B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Antibe Therapeutics (ATBPF) Canada $0.071B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
ARAVIVE, INC (ARAV) United States $0.070B 0.00
VTv Therapeutics (VTVT) United States $0.070B 0.00
Curis (CRIS) United States $0.068B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.066B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
VBI Vaccines (VBIV) United States $0.064B 0.00
Unum Therapeutics (UMRX) United States $0.064B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Applied Genetic Technologies (AGTC) United States $0.058B 31.80
Prima BioMed (IMMP) Australia $0.058B 0.00
Oncobiologics (OTLK) United States $0.055B 0.00
AIT Therapeutics (XAIR) United States $0.054B 0.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
Ophthotech (ISEE) United States $0.049B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Signal Genetics (MGEN) United States $0.042B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Celsion (CLSN) United States $0.039B 0.00
Protalix BioTherapeutics (PLX) Israel $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.037B 0.00
Aptevo Therapeutics (APVO) United States $0.037B 0.00
VIVUS (VVUS) United States $0.036B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
Proteostasis Therapeutics (PTI) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.032B 0.00
Entera Bio (ENTX) Israel $0.031B 0.21
DiaMedica Therapeutics (DMAC) United States $0.029B 0.00
VistaGen Therapeutics (VTGN) United States $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
Soligenix (SNGX) United States $0.021B 0.00
Vical (VICL) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.27
Bionano Genomics (BNGO) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Novogen (KZIA) Australia $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
CollPlant Holdings (CLGN) Israel $0.014B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
AmpliPhi Biosciences (ARMP) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Hemispherx BioPharma (HEB) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
BioPharmX (BPMX) United States $0.003B 0.00
Neuralstem (CUR) United States $0.002B 0.00